Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling

University of Electronic Science and Technology of China

Transplantation Proceedings, 19 Aug 2026

doi.org/10.1016/j.transproceed.2026.07.016PubMed 42618414